CRKL oncogene is downregulated by p53 through miR‐200s

E-ISSN： 1349-7006|106|8|1033-1040

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.8, 2015-08, pp. : 1033-1040

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual tumor‐suppressors miR‐139‐5p and miR‐139‐3p targeting matrix metalloprotease 11 in bladder cancer

Cancer Science, Vol. 107, Iss. 9, 2016-09 ,pp. : 1233-1242

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐181a induces sorafenib resistance of hepatocellular carinoma cells through downregulation of RASSF1 expression

Cancer Science, Vol. 107, Iss. 9, 2016-09 ,pp. : 1256-1262

John Wiley & Sons Inc

Access to resources Recommend Favorite

Magnolol inhibits growth of gallbladder cancer cells through the p53 pathway

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1341-1350

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long non‐coding RNA Fer‐1‐like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR‐106a‐5p in colon cancer

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1323-1332

John Wiley & Sons Inc

Access to resources Recommend Favorite

53BP1 suppresses epithelial–mesenchymal transition by downregulating ZEB1 through microRNA‐200b/429 in breast cancer

Cancer Science, Vol. 106, Iss. 8, 2015-08 ,pp. : 982-989

John Wiley & Sons Inc

Access to resources Recommend Favorite